Potent mitochondria-targeted peptides reduce myocardial infarction in rats - PubMed (original) (raw)
Clinical Trial
Potent mitochondria-targeted peptides reduce myocardial infarction in rats
Janghyun Cho et al. Coron Artery Dis. 2007 May.
Abstract
Objective: Previously, we demonstrated that a novel opiate peptide, 2',6'-dimethyl-tyrosine-D-Arg-Phe-Lys-NH2, provided cardioprotection against myocardial stunning in vivo. We subsequently showed that this peptide targeted mitochondria and can scavenge reactive oxygen species. The objective of this study was to determine the role of opioid versus antioxidant activity in cardioprotection.
Methods: We compared two mitochondria-targeted peptide analogs that lacked opioid activity: SS-31 (D-Arg-2',6'-dimethyl-tyrosine-Lys-Phe-NH2) and SS-20 (Phe-D-Arg-Phe-Lys-NH2). They differ in that only SS-31 has scavenging ability. Rats (n=8/group) were randomized to SS-31, SS-20 or placebo. The drugs (3 mg/kg) or saline was administered intraperitoneally 30 min before ligation of the left anterior descending artery for 60 min, and another dose given intraperitoneally 5 min before reperfusion for 60 min. Study endpoints included myocardial infarct size, cardiac arrhythmia and myocardial lipid peroxidation.
Results: The area at risk was similar among the groups. The infarct area/area at risk, however, was significantly smaller in the treatment groups (53.9+/-1.1% in SS-31 group, 47.1+/-1.4% in SS-20 group, versus 59.9+/-1% in the controls, P<0.01). Lipid peroxidation was significantly reduced by both SS-31 and SS-20 treatment. Arrhythmia occurred only during the early period of coronary occlusion and was less frequent and less severe in the peptide treatment groups than in the controls (Lambeth score 5 points, 3 points, versus 13 points in the controls, P<0.05).
Conclusions: This study shows that pretreatment with both SS-31 and SS-20 significantly reduced myocardial lipid peroxidation and infarct size in ischemia-reperfusion injury, and suggests that the cardioprotective properties of 2',6'-dimethyl-tyrosine-D-Arg-Phe-Lys-NH2 was primarily mediated by its antioxidant properties. As SS-20 does not scavenge reactive oxygen species, it most likely reduces reactive oxygen species production during ischemia-reperfusion.
Similar articles
- Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.
Nie R, Xia R, Zhong X, Xia Z. Nie R, et al. Can J Physiol Pharmacol. 2007 Oct;85(10):1012-9. doi: 10.1139/y07-092. Can J Physiol Pharmacol. 2007. PMID: 18066102 - Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines.
Zhao K, Luo G, Giannelli S, Szeto HH. Zhao K, et al. Biochem Pharmacol. 2005 Dec 5;70(12):1796-806. doi: 10.1016/j.bcp.2005.08.022. Epub 2005 Oct 10. Biochem Pharmacol. 2005. PMID: 16216225 - A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats.
Song W, Shin J, Lee J, Kim H, Oh D, Edelberg JM, Wong SC, Szeto H, Hong MK. Song W, et al. Coron Artery Dis. 2005 Sep;16(6):407-10. doi: 10.1097/00019501-200509000-00011. Coron Artery Dis. 2005. PMID: 16118547 - Cell-permeable, mitochondrial-targeted, peptide antioxidants.
Szeto HH. Szeto HH. AAPS J. 2006 Apr 21;8(2):E277-83. doi: 10.1007/BF02854898. AAPS J. 2006. PMID: 16796378 Free PMC article. Review. - Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease.
Mailloux RJ. Mailloux RJ. Curr Pharm Des. 2016;22(31):4763-4779. doi: 10.2174/1381612822666160629070914. Curr Pharm Des. 2016. PMID: 27356774 Review.
Cited by
- Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.
Marzetti E, Csiszar A, Dutta D, Balagopal G, Calvani R, Leeuwenburgh C. Marzetti E, et al. Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H459-76. doi: 10.1152/ajpheart.00936.2012. Epub 2013 Jun 7. Am J Physiol Heart Circ Physiol. 2013. PMID: 23748424 Free PMC article. Review. - Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W, Cheung E, Alleman RJ, Perry JB, Allen ME, Brown DA, Kloner RA. Dai W, et al. Cardiovasc Drugs Ther. 2016 Dec;30(6):559-566. doi: 10.1007/s10557-016-6695-9. Cardiovasc Drugs Ther. 2016. PMID: 27747447 Free PMC article. - Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice.
Bhatti JS, Thamarai K, Kandimalla R, Manczak M, Yin X, Kumar S, Vijayan M, Reddy PH. Bhatti JS, et al. Mol Neurobiol. 2021 Feb;58(2):795-808. doi: 10.1007/s12035-020-02142-7. Epub 2020 Oct 7. Mol Neurobiol. 2021. PMID: 33025510 Free PMC article. - Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X, Manczak M, Reddy PH. Yin X, et al. Hum Mol Genet. 2016 May 1;25(9):1739-53. doi: 10.1093/hmg/ddw045. Epub 2016 Feb 16. Hum Mol Genet. 2016. PMID: 26908605 Free PMC article. - Cardiac aging: from molecular mechanisms to significance in human health and disease.
Dai DF, Chen T, Johnson SC, Szeto H, Rabinovitch PS. Dai DF, et al. Antioxid Redox Signal. 2012 Jun 15;16(12):1492-526. doi: 10.1089/ars.2011.4179. Epub 2012 Apr 3. Antioxid Redox Signal. 2012. PMID: 22229339 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials